Scientific Program

S16
Innovations and the latest approach in managing ACHD patients with Heart Failure and Transplantation

Chair: Hannes Sallmon, Germany
Co-chair: Werner Budts, Belgium

Delivering patient centred care to adults with congenital heart disease and heart failure – what we can learn from the Covid 19 pandemic,
Louise Coats, UK
What can a global registry for outcomes in ACHD transplant deliver – introduction to Artoria R ,
Christopher Sinning, Germany
Delivering cavopulmonary support to the failing Fontan circulation -is the dream becoming a reality,
Peter Kramer, Germany
Determining the Optimal Transplant Listing Window for Patients with Fontan Physiology,
Clive Lewis, UK
Atrial flow Regulator (AFR) implantation in potential heart transplant recipients,
Nikolaus Haas, Germany

AS07
Pulmonary Hypertension, Heart Failure and Transplantation
Chair: Julie Wacker, Switzerland
Co-chair: Colin McMahon, Ireland

O-043 Transcatheter creation of a restrictive atrial communication for treatment of patients with heart failure and hypertensive left atrial pressures,
Mustafa Gülgün, Germany
O-044 The preponderance of genetic involvement in paediatric pulmonary hypertension,
Julien Grynblat, France
O-045 Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model,
Giuseppina Milano, Switzerland
O-046 Validation of the New EPPVDN Pediatric Pulmonary Hypertension Risk Score by Cardiac Magnetic Resonance Imaging and Speckle Tracking Echocardiography,
Hosan Hasan, Germany
O-047 Long-Term Outcomes of Transcatheter Potts Shunt in Children with Suprasystemic Pulmonary Arterial Hypertension,
Raymond N. Haddad, France
O-048 Full recovery of right ventricular systolic function in children undergoing bilateral lung Transplantation for severe pulmonary arterial hypertension,
Georg Hansmann, Germany

S23
Challenges in Paediatric Heart Transplantation

Chair: Maurice Beghetti, Switzerland
Co-chair: Taisto Sarkola, Finland

Rising to the challenge, this intervention can really delay transplant,
Milind Chaudhari, UK
Heart transplant rejection with haemodynamic compromise - treatment options,
Zdenka Reinhardt, UK
Integrating approaches for heart transplant rejection assessment. Is endomyocardial biopsy still necessary?,
Ina Michel-Behnke, Austria
Ideal post heart transplant shared care model,
Colin McMahon, Ireland

S27
Challenges in Paediatric Heart Failure in small children with cardiomyopathy Transplantation
Seperate / WG: Pulmonary Hypertension, Heart Failure and Transplantation
Chair: Zdenka Reinhardt, UK
Co-chair: Georg Hansmann, Germany

Disruption of sodium-dependent vitamin transport: a potential novel cause of cardiomyopathy,
Lauren Philips, UK
Precision medicine in cardiomyopathy,
Barbara Cardoso, UK
Debate: Pro Pro Medical Heart Failure Management of patient with DCM less than 5 kg,
Julie Wacker, Switzerland
Debate: Pro VAD support of patient with DCM less than 5 kg,
Oliver Miera, Germany

Young Investigator Award

Chair: Ina Michel-Behnke, Austria
Co-chair: Hiroyuki Yamagishi, Japan

O-031 Transcatheter Correction of Sinus Venosus Atrial Septal Defect: From Bench Testing to Clinical Success
Clement Batteux, France
O-032 Perinatal Hypoxia Aggravates Occlusive Pulmonary Vasculopathy In Rats Later In Life: Association With Epigenetic Changes,
Hironori Oshita, Japan
O-033 Kawasaki disease and the current SARS-CoV-2 pandemic: rare lessons from a cohort of more than 1000 Kawasaki patients in The Netherlands,
Stejara A Netea, Netherlands
O-034 The critical role of ER selective autophagy in response to Doxorubicin-induced myocardial injury,
Shun Nakagama, Japan
O-035 Percutaneous transhepatic periportal embolization of hepato-duodenal lymphatic fistulae as treatment for protein losing enteropathy after Fontan
Thomas Salaets, Belgium
O-036 Low- versus high-concentration intravenous immunoglobulin for children with Kawasaki disease in the acute phase,
Takanori Suzuki, Japan

"HAUSDORF LECTURE"
“Be aware of the written word!”

Chairs: Shakeel Qureshi & Regina Bokenkamp

Keynote: Marc Gewillig, Belgium

AS08
Cardiac Imaging / functional assessment
Chair: TBA
Co-chair: Leo Lopez, United States

O-049 MRI lymphangiography in children: a single centre experience,
Valentina Benetti, UK
O-050 Non-invasive assessment of myocardial work in adolescents and young adults with effectively corrected versus residual aortic coarctation,
Miguel Fogaça Da Mata, Portugal
O-051 Cardiac catheter examination in Kawasaki disease: Initial data from the Central European Registry,
Julia Weisser, Germany
O-052 Use of Speckle Tracking Echocardiography to detect Anthracycline-Induced Cardiotoxicity in Childhood Cancer: A Prospective Controlled study,
Marie Vincenti, France
O-053 Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography in Prosthetic Pulmonary Valve Infective Endocarditis,
Maelys Venet, Canada

S20
Morphological Session: Morphology of the ductus arteriosus

Chair: Annalisa Angelini, Italy
Co-chair: Regina Bokenkamp, Netherlands

Isolated patent ductus arteriosus,
Loucile Houyel, France
Ductus arteriosus in duct-dependent circulation,
Adam Kolesnik, Poland
Ductus arteriosus wall after intervention,
Matthias Sigler, Germany

S22
Indian Society Session

Cardiac tumors in pediatric patients
Chair: Sunita Maheswari, India
Co-chair: Nico Blom, Netherlands

Incidence, symptomatology and outcome of cardiac tumors in the pediatric age group,
Sivasubramanian Ramakrishnan, India
Natural history and therapeutic approach of neoanatal rhabdomyomas,
Sunita Maheswari, India
Differential diagnosis of pediatric cardiac tumors: the role of multimodality imaging,
Kai Thorsten Laser, Germany
Surgery of cardiac tumors in children: when and how,
René Prêtre, Switzerland

S28
TGA/DORV with Pulmonary outflow tract stenosis
Chair: Hitendu Dave, Switzerland
Co-chair: George Sarris, Greece

The REV procedure, superior to the Rastelli operation.,
Pascal Vouhé, France
Reoperations after a Rastelli procedure,
René Prêtre, Switzerland
The Nikaidoh / Root rotation procedure,
Tornike Sologashvili, Switzerland
Biventricular repair of double-outlet right ventricle with noncommitted ventricular septal defect,
François Lacour-Gayet, France

S18
Pulmonary Hypertension- Prevention, Physical Activity and competitive Sports

Chair: Martin Koestenberger, Austria
Co-chair: Renate Oberhoffer-Fritz, Germany

State of the Art in Diagnostics in PAH,
Maurice Beghetti, Switzerland
State of the art in therapy and prevention in PAH,
Georg Hansmann, Germany
State of the Art in Physical Activity and Sportscardiology in PAH,
Martin Koestenberger, Austria
Case report: PAH and some other issues
Sulaima Albinni, Austria
Case Report: PAH and exercise
Julia Hock, Germany

MP02
Sports Cardiology, Physical Activity and Prevention
Chair: Erzsébet Valéria Hidvégi, Hungary
Co-chair: Renate Oberhoffer-Fritz, Germany

P-148 Different profiles of lipoprotein particles associate various degree of cardiac involvement in adolescents with morbid obesity, José Manuel Siurana, Spain

P-144 Impact of lockdown on cardiopulmonary function in children with heart disease, Isabelle Schöffl, Germany

P-155 Association between objectively measured physical activity and exercise capacity in children with congenital heart disease, Laura Willinger, Germany

P-139 Preclinical aortic atherosclerosis in adolescents with chronic disease, Henk Schipper, Netherlands

P-156 Effect of physical activity on cardiovascular health in six-year-old children born to mothers with high cardiometabolic risk, Linda Litwin, Poland

P-130 Risk Factors for Perioperative Brain Lesions on MRI in Infants with Severe Congenital Heart Disease: A European Collaboration, Alexandra Bonthrone, UK

P-150 Motor function in children and adolescents with CHD in a direct twin comparison – same same, but different?, Julia Remmele, Germany

P-169 Adverse arterioventricular interaction in adolescents with chronic disease, Victor Verpalen, Netherlands

P-134 Common carotid artery characteristics in patients with repaired aortic coarctation compared to other cardiovascular risk factors, Constance G Weismann, Germany

P-159 COVID-19 vaccination from 6 to 17 years carries a similar risk for fatal or life-threatening myocarditis than being struck by lightning, Massimiliano Cantinotti , Italy

P-145 Investigating the relation between hemoglobin a1c with left ventricular remodeling patterns in children with type 1 diabetes mellitus, Iulia Rodoman, Moldova

P-138 1. Lack of improvement in the postnatal detection of heart defects, Gunnar Wik, Norway

MP04
Paediatric Cardiovascular Intensive Care & Adult congenital heart disease & Prevention
Chair: Judith Bouchardy, Switzerland
Co-chair: Massimo Chessa, Italy

P-489 Determining factors for hs-Troponin T and NT-proBNP in a cohort of healthy children (The LIFE child study), Alexandra Kiess, Germany

P-353 Surgical Treatment of the Aortic Coarctation Depending on the Anatomical Characteristics, Hyungtae Kim, South Korea

P-372 Health-Related Quality of Life of Ugandan Children following Valve Replacement Surgery for Rheumatic Heart Disease., Mohammed Ahmed Mohammed, Turkey

P-370 Factors associated with acute kidney injury after cardiopulmonary bypass in children, Michael Nicolas Gritti, Canada

P-017 Bioelectrical impedance analysis as a potential risk marker in adults with Marfan syndrome, Mathieu Suleiman, Germany

P-009 Home-based resistance training in Fontan patients: it’s feasible, safe and efficient!, Joanie Gagnon, Canada

P-168 Nutritional Diagnosis in children with congenital heart disease and parental characteristics in a social program in a Latin American country, Victor M. H. Quinones, Colombia

P-135 Does pulse wave analysis by digital plethysmography reliably assess arterial stiffness in patients with congenital heart disease?, Constance G Weismann, Germany

S29
Arrhythmias in adult CHD patients
Chair: Alexander Van De Bruaene, Belgium
Co-chair: Tomasz Ksiazczyk, Poland

ICD in primary prevention for the systemic RV: who and when?,
Fabrizio Drago, Italy
EP study +- ablation prior to pulmonary valve replacement in tetralogy of Fallot?,
Nico Blom, Netherlands
Ablation of atrial arrhythmias in Fontan patients: a Sisyphean task?,
Joris Ector, Belgium

S19
Corrected transposition of the great arteries – Timing and technique

Chair: Roberto Di Donato, Italy
Co-chair: René Prêtre, Switzerland

The true anatomy of the L-TGA,
Nicolas Arribard, Belgium
Indications for a physiological or anatomical repair,
Massimo Padalino, Italy
The role of PA banding in L-TGA,
Nicole Sekarski, Switzerland
The hemi-Mustard vs the full Mustard/Senning atrial switch in L-TGA,
Hitendu Dave, Switzerland

AS09
Interventional cardiology

Chair: Stefano Di Bernardo, Switzerland
Co-chair: Massimo Chessa, Italy

O-055 Ductus arteriosus stenting versus Blalock-Taussig shunt for infants with ductal-dependent pulmonary circulation: a comparative international study
Zakaria Jalal, France
O-056 A New Self Expandable Valve; Pulsta THV in Patients with Enlarged RVOT and Severe Pulmonary Regurgitation due to Transannular Patch
Ender Ödemiş, Turkey
O-057 Percutaneous edge to edge repair for systemic tricuspid valve regurgitation in patients with congenital heart disease: the first descriptive cohort
Patrice Guerin, France
O-058 Ductal stenting versus RVOT stenting in infants with tetralogy of Fallot and duct dependant pulmonary circulation
Enrico Piccinelli, UK
O-059 Transcatheter closure of ventricular septal defects with LifeTech multifunctional occluder device (MF- Konar)- a single-center experience
Alper Guzeltas, Turkey
O-060 Pulmonary artery stenting after bidirectional cavopulmonary connection (BDCPC) in Single Ventricle patients: necessity and benefit,
Alessia Callegari, Switzerland

NS06
Florence Nightingale Lecture

Being in the right place at the right time over 40 years in pediatric cardiology: Lessons learned and ways forward

Chair: Gaby Stoffel, Switzerland
Keynote: Gwen R. Rempel, Canada

S24
ECG Quiz

Chair: Joachim Hebe, Germany
Co-chair: Juha-Matti Happonen, Finland

S30
Puzzle the Experts

Chair: Annika Öhman, Sweden
Co-chair: Sally Ann Clur, Netherlands

Vlasta Fesslova, Italy
Sophie Duignan, Ireland
Ingmar Knobbe, Netherlands

S17
Canadian Society Session

Chair: Kenny Wong, Canada
Co-chair: Anne Fournier, Canada

The echo findings related to need for and results of resynchronization therapy,
Mark Friedberg, Canada
Cardiac resynchronization in pediatrics and CHD reviewing indications and outcomes,
Carolina Escudero, Canada
Conduction system pacing in congenital heart disease,
Goetz Buchwalsky, Germany
Cardiac resynchronization of the subpulmonary ventricle,
Jan Janousek, Czech Republic

MP03

Cardiac Dysrhythmias and Electrophysiology & Genetics, Basic Science and Myocardial Disease

Chair: Alice Maltret, France
Co-chair: Nico Blom, Netherlands

P-217 AVNRT cryoablation in children < 26 Kg: efficacy and safety of electrophysiologically guided low voltage bridge strategy, Cristina Raimondo, Italy

P-248 Clinical characteristics and mid-term follow-up findings in children with isolated complete heart block: A single-center ten-year experience, Yakup Ergul, Turkey

P-254 Clinical course and electrophysiological characteristics of permanent junctional reciprocating tachycardia in children: ten years experience, Yakup Ergul, Turkey

P-207 Two broken pacemaker cans in one patient, Anna Cavigelli Brunner, Switzerland

P-247 Epicardial device migration in children – a rare but important complication, Tomasz Marcin Ksiazczyk, Poland

P-225 Catheter ablation of accessory pathways in children and patients with congenital heart disease: Predictors of outcome, John Papagiannis, Greece

P-257 Cardioneuroablation in a pediatric patient with Type IIb cardioinhibitory vasovagal syncope and functional advanced AV block, Yakup Ergül, Turkey

P-476 Clinical symptoms in children with genetic aortopathy and their response to medical therapy – A monocentric analysis over more than one decade, Jakob Olfe, Germany

P-487 Induced pluripotent stem cell-derived Chagas disease model highlights the role of cardiomyocytes as sentinels of the host-parasite interaction, Yu Nakagama, Japan

P-472 Homozygous Genetic Variant in Desmin Causes Severe Inflammatory Cardiomyopathy, Franziska Seidel, Germany

P-479 Arrhythmia and impaired myocardial function in Heritable Thoracic Aortic Disease: an international retrospective cohort study, Laura Muiño Mosquera, Belgium

P-474 Concerns about safety of growth hormone therapy in Noonan syndrome and other RASopathies: risk of triggering or worsening hypertrophic cardiomyopathy, Ingegerd Östman Smith, Sweden

AS05
Cardiac Dysrhythmias and Electrophysiology

Chair: Christian Balmer, Switzerland
Co-chair: Maria Cecilia Gonzalez, UK

O-061 Electrocardiographic and electrophysiological characteristics of fasciculoventricular fibers in children: Single-center 8-years experiencei
Yakup Ergul, Turkey
O-062 Assessment in a geographical cohort of PRIMaCY performance for risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy,
Eva Fernlund, Sweden
O-063 Arrhythmogenic cardiomyopathy in childhood,
Marit Kristine Smedsrud, Norway
O-064 Electrophysiologic characteristics and catheter ablation results of fascicular ventricular tachycardia in children,
Alper Güzeltaş, Turkey
O-065 Retrospective single-centre study of paediatric catheter ablation in the era of 3D navigation and mapping,
Jiri Houda, Czech Republic
O-066 Long-term fate of an unselected cohort of congenital long QT syndrome patients diagnosed in childhood,
Terezia Tavacova, Czech Republic

S25
Fetal cardiovascular magnetic resonance imaging for prenatal diagnosis of complex congenital heart defects

Chair: Margarita Bartsota, Cyprus
Co-chair: Alexander Kovacevic,Germany

Feasibility of non-gated dynamic fetal cardiac MRI for identification of fetal cardiovascular anatomy,
Emanuela Valsangiacomo, Switzerland
Explanation of physics, technique of the MR conditional DUS gating device,
Fabian Kording, Germany
Fetal MRI – from research to clinical practice,
David Lloyd, UK
Utility of fetal CMR for prenatal diagnosis of complex congenital heart defects,
Katrin Fricke, Sweden

BREAK

S31
Artificial Inteligence and Cardiac Intensive Care

Chair: Nicole Sekarski, Switzerland
Co-chair: Nikolaus Haas, Germany

Artificial intelligence in the Cardiac Intensive Care,
Patricia Garcia Cañadilla, Spain
How to use Data to improve Patient Outcomes,
Sarah Tabbutt, United States
Remote Telemonitoring in the Cardiac Intensive Care,
Ricardo Munoz, United States
High Value Care Approach for patients with Congenital Heart Disease,
Joan Sanchez-de-Toledo, Spain

NS04
Long-term perspectives after transplantation in CHD pts

Chair: Damien Bonnet, France
Co-chair: Corina Thomet, Switzerland

How to manage problems affecting long-term outcomes after heart transplantation,
Zdenka Reinhardt, UK
Long-term outcome impacting quality of life, cognition and development,
Jo Wray, UK
Role of transplantation and ventricular assist devices in CHD patients,
Justyna Rybicka, UK
Patient Journey,
Lynda Saughnessy, UK

NS05
Optimizing the journey towards surgery in CHD patients

Chair: Justyna Rybicka, UK
Co-chair: Gaby Stoffel, Switzerland

Pre-operative Information: perspectives of patients, family and healthcare teams,
René Prêtre, Switzerland
Preparing patients and Parents for ICU post cardiac surgery,
Nadya Golfenshtein, Israel
Nutrition therapy in the perioperative setting,
Larissa Flückiger, Switzerland
Can physiotherapy optimize and influence outcomes in ACHD surgical patients?,
Linda Ashman Kröönström, Sweden

AS10
Sports Cardiology, Physical Activity and Prevention

Chair: Albane Maggio, Switzerland
Co-chair: Doris Ehringer Schetiska, Austria

O-067 Physical fitness, BMI, health-related quality of life and mental concentration – Cross-sectional cardiovascular risk data of a large school cohort,
Katharina Appel, Germany
O-068 Impact of a transition education program on health-related quality of life in adolescents and young adults with congenital heart disease,
Pascal Amedro, France
O-069 Reference values for cardiorespiratory fitness in children and adolescents with congenital heart disease,
Vibeke Klungerbo, Norway
O-070 Return to play after SARS-CoV-2 infection: safe sport for children and adolescents,
Giulia Cafiero, Italy
O-071 Cognitive function in children with CHD impaired in a direct twin comparison,
Julia Remmele, Germany

AS11
General Cardiology

Chair: Walter Knirsch, Switzerland
Co-chair: Maya Bouhabib, Switzerland

O-073 Congenital heart defects and their association with maternal diabetes and overweight during pregnancy: a register-based study from Finland,
Riitta Turunen, Finland
O-074 The Congenital Cardiology Cloud – proof of feasibility of the first telemedical network for pediatric cardiology in Germany,
Kathrin Rottermann, Germany
O-075 National Paediatric Mortality secondary to Cardiac Causes: An Irish experience,
Li Yen Ng, Ireland
O-076 Outflow Anatomy in Double-outlet Right Ventricle,
Matthias Sigler, Germany
O-077 Improved Endothelialization in the Regenerative Small Diameter Vascular Grafts with SNAP Loaded Nanoparticles,
Fatemeh Kabirian, Belgium
O-078 The value of Galectin-3 in pediatric acute rheumatic fever,
Mehmet Gökhan Ramoğlu, Turkey

S33
Successes and failures in the cathlab

Chair: Regina Bokenkamp, Netherlands
Co-chair: Shakeel Qureshi, UK

Million Pound boy, Sonia EL Saiedi, Egypt
LPA problems, Afrodite Tzifa, Greece
Hemorrhage, Ender Ödemiş, Turkey
Connecting right and left, Nathan Hahurij, Netherlands

S37
Outcome measures in CHD reserach

Chair: Michal Odermarsky, Sweden
Co-chair: Katya De Groote, Belgium

Biomarkers in congenital heart disease,
Wim Helbing, Netherlands
New imaging modalities for the assessment of heart failure,
Thorsten Laser, Germany
The introduction of new devices: RCT's or registries,
Thomas Krasemann, Netherlands
Tools to measure quality of life and psychosocial effects in research in CHD,
Christopher McCusker, UK

S34
Tell your pediatric colleagues: how is the patient doing in adulthood?

Chair: Werner Budts, Belgium
Co-chair: Judith Bouchardy, Switzerland

The arterial switch procedure: really that good?,
Paolo Ferrero, Italy
The older Fontan patient: why is he/she still failing?,
Damien Cullington, UK
The single ventricle patient who did not undergo Fontan palliation: how is he/she doing?,
Alexander Van De Bruaene, Belgium
The systemic RV: was is eventually heart failure or SCD?,
Magalie Ladouceur, France

S38
Systemic right ventricle - basic and clinical aspects

Chair: Joanna Dangel, Poland
Co-chair: Annalisa Angelini, Italy

Development and morphology of RV in subpulmonary and subsystemic position,
Loucile Houyel, France
Remodeling of systemic right ventricle,
Beatrijs Bartelds,Netherlands
Prenatal assessment of systemic right ventricle,
Sally Ann Clur, Netherlands
Systemic right ventricle - surgical aspects,
Hitendu Dave, Switzerland
Adult with systemic right ventricle,
Alexander Van De Bruaene, Belgium

AS12
Paediatric Cardiovascular Intensive Care

Chair: Damian Hutter, Switzerland
Co-chair: Nikolaus Haas, Germany

O-079 A bicentric propensity matched analysis of 158 patients comparing porcine versus bovine stented bioprosthetic valves in pulmonary position,
Bunty Ramchandani, Spain
O-080 Surgical Repair of Obstructed Total Anomalous Pulmonary Venous Connection in Infants: Results and Risk Factors for Mortality in a Single Centre Cohort,
Avishek Samaddar, United Kingdom
O-081 Aortic Root Dilatation after Ross Operation,
Nerejda Shehu, Germany
O-082 Effect of Platelet Transfusions on Extracorporeal Life Support Oxygenators' Function,
Oliver Karam, United States
O-083 Renal and Cardiac Effects of Remote Ischemic Preconditioning in Children Undergoing Cardiopulmonary Bypass Surgery,
Yuk Law, United States
O-084 Necrotizing enterocolitis and congenital heart disease,
Claire Bertail Galoin, France

MP05
Cardiac Imaging / functional assessment & Interventional cardiology

Chair: Oliver Kretschmar, Switzerland
Co-chair: Emanuela Valsangiacomo, Switzerland

P-082 Neonatal cardiac, feed-and-wrap, free-breathing 4D Flow MRI is comparable to standard free-breathing 2D Flow assessment, Hannah Panayiotou, UK
P-063 The role of cardiac magnetic resonance imaging in pediatric myocarditis, Alper Guzeltas, Turkey
P-057 Reduced neonatal fronto-limbic connectivity is associated with higher externalizing symptoms in toddlers with Congenital Heart Disease, Alexandra Bonthrone, UK
P-085 Validation of various approaches to aorta, pulmonary artery and pulmonary branches measurements in CT scans, Jarosław Meyer Szary, Poland
P-119 Myocardial strain response to a preload challenge in the Fontan circulation, Simone Goa Diab, Norway
P-192 Piccolo in Interventional PDA Closure; Multicenter Study from Premature to Adolescent, Osman Baspinar, Turkey
P-322 First in Man Use of a Novel FDA Approved Stent Design for Congenital Heart Disease- the G-ARMOR Stent, Gareth Morgan, United States
P-181 How is the Melody™ TPV doing 15 years after implantation ?, Marc Gewillig, Belgium
P-200 Importance of RVOT gradient in the diagnosis of transcatheter pulmonary valve endocarditis, Salaets Thomas, Belgium
P-292 Institutional experience with the Occlutech© atrial flow regulator (AFR) in children with congenital heart disease, Adam Koleśnik, Poland
P-297 Implantation of a new transcatheter heart valve for pulmonary position: Meril's Myval™, Alper Guzeltas, Turkey
P-294 Does pulmonary artery stenting in single ventricle patients affect lung growth and function?, Alessia Callegari, Switzerland

S35
Clinical Management of Pre- and Post-Capillary Pulmonary Hypertension, including ECLS and Transplantation

Chair: Martin Köstenberger, Austria
Co-chair: Ina Michel-Behnke, Austria

Risk Stratification in Paediatric Pulmonary Hypertension,
Damien Bonnet, France
Risk Assessment and Advanced Therapies for RV Failure in severe PAH,
Georg Hansmann, Germany
Pulmonary Vascular Resistance in Left Heart Disease- Implications for Mechanical Circulatory Support and Heart Transplantation,
Karin Tran-Lundmark, Sweden
Advanced Therapies for Postcapillary Pulmonary Hypertension (HLHS variants, cardiomyopathies),
Maurice Beghetti, Switzerland

S39
Novelties in the indications and management of CIED in pediatric patients

Chair: Fabrizio Drago, Italy
Co-chair: Maully Shah, United States

Expert Consensus Statement on the Indications and Management of CIED in Pediatric Patients – what is new?,
Maully Shah, United States
Leadless pacing – real option in children and GUCH patients?,
Eric Rosenthal, UK
His-bundle pacing – EP,
Roman Gebauer, Italy
Non-transvenous pacing and ICD systems – presence and future perspectives,
Johannes Von Alvensleben, United States

AS13
Cardiac Dysrhythmias and Electrophysiology

Chair: Birgit Donner, Switzerland
Co-chair: Thomas Kriebel, Germany

O-085 Typical AVNRT - underestimated arrhythmia after atrial redirection surgery for d-transposition of the great arteries? 20 years of catheter ablation,
Stephan Neumann, Germany
O-086 Action potential shape in right ventricular myocardium of patients with congenital heart defects is related to fibrosis and disease severity,
Hannah Elisabeth Fürniss, Germany
O-087 Coronary sinus ablation in pediatric patients with supraventricular arrhythmias; eight years single-center experience,
Alper Güzeltaş, Turkey
O-088 The effect of electro-anatomical mapping on the success rate and fluoroscopy time in supra-ventricular tachycardia ablation in children,
Robin Andrew Bertels, Netherlands
O-089 Cheek smear analysis as a prognostic tool in children with arrhythmogenic cardiomyopathy,
Carlos Bueno-Beti, UK
O-090 Electrophsiologic study characteristics and risk assessment in patients with intermittent vs persistent ventricular preexcitation,
Yakup Ergül, Turkey

AS14
Paediatric Cardiovascular Intensive Care

Chair: Tornike Sologashvili, Switzerland
Co-chair: Nicole Sekarski, Switzerland

O-091 Short to long-Term outcome of patients implanted with a telemetric adjustable pulmonary artery banding device FloWatch-PAB® in Switzerland, Sara Valerie De Meyer, Switzerland
O-092 Hospital Survival has Improved in Neonates with Congenital Heart Disease Supported on Prolonged ECMO – An ELSO registry based cohort study, Shashi Raj, United States
O-093 Personalised External Aortic Root Support (PEARS) applied for dilatation aortopathies in paediatric patients, Ana Redondo, UK
O-094 Complete atrio-ventricular septal defect: Modified 2-patches technique, Raymond Pfister, Switzerland
O-095 Presence of multiple preoperative risk factors (≥ 3) is associated with poor prognosis in an 11-year national cohort of HLHS patients, Sabina Selenius, Finland
O-096 Does additional pulmonary anterograde flow at the Glenn procedure improve pulmonary artery growth and at what cost?, Lyudmil Simeonov, Bulgaria

NS07
Methods corner: Novel interventional studies assessing outcomes in patients with CHD

Chair: Ewa-Lena Bratt, Sweden
Co-chair: Malin Berghammer, Sweden

Neurodevelopmental outcomes,
Johanna Calderon, France
Transition-related outcomes,
Mariela Acuna Mora, Sweden
Lifestyle and behavioral outcomes,
Cristopher McCusker, Ireland
Economic and health policy outcomes,
Ruben Willems, Belgium

AS15
COVID-19
Chair: Skaiste Sendzikaite, Switzerland
Co-chair: Sabrina Bressieux-Degueldre, Switzerland

O-097 Three-dimensional echocardiography and global longitudinal strain in the assessment of left ventricular function in children after PIMS-TS,
Halszka Kamińska, Poland
O-098 Increase in Kawasaki disease incidence observed in 30-year population-based study in Scandinavia,
André Rudolph, Sweden
O-099 Complete resolution of cardiac sequelae is seen in patients treated for paediatric multisystem inflammatory syndrome (PIMS) by 12 months,
Sally Hall, UK
O-100 A comparative study of cardiac involvement of Kawasaki Disease and Multisystem Inflammatory Syndrome post Covid (MISC) in children,
Debadatta Mukhopadhyay, India
O-101 Kawasaki disease in the time of COVID-19 – The International Kawasaki Disease Registry,
Ashraf S Harahsheh, United States
O-102 Anakinra in treatment of Pediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV2 infection (PIMS-TS) with cardiac involvement,
Joanna Lea Friedman Gruszczynska, Poland